JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A4452 Mitomycin C
3 Citation

Summary: Inhibits DNA synthesis,antibiotic and antitumor agent

insoluble in H2O; insoluble in EtOH; ≥16.7 mg/mL
A2402 Floxuridine

Target: Synthases/Synthetases

Summary: Antineoplastic antimetabolite

≥12.31 mg/mL
A2171 Carboplatin

Summary: Antitumor agent that forms platinum-DNA adducts.

insoluble in ETOH; ≥9.28 mg/mL
A1402 Gemcitabine HCl

Summary: Inhibits DNA synthesis,deoxycytidine analog

≥10.1 mg/mL
A1206 Daptomycin
1 Citation

Summary: Calcium-dependent antibiotic

≥81.03 mg/mL
A2187 Cladribine

Target: Adenosine Deaminases

Summary: Apoptosis inducer in CLL cells

≥41.67 mg/mL
A2197 Dacarbazine

Target: DNA Alkylating

Summary: Antineoplastic( malignant melanoma and sarcomas)

insoluble in EtOH; ≥0.54 mg/mL
A2097 Ifosfamide

Target: DNA Alkylating

Summary: Cytostatic agent

≥13.05 mg/mL
A2451 Epirubicin HCl

Target: Topoisomerases

Summary: Antibiotic antitumor agent

≥29.00 mg/mL
A1379 Nelarabine

Summary: Prodrug of ara-G for T-LBL/T-ALL

insoluble in EtOH; ≥14.85 mg/mL